Loading...
Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection
CONTEXT: Traditional hepatitis C virus treatment was limited by low cure rates, side effects, and stringent monitoring requirements. Sofosbuvir, a direct-acting antiviral agent with a cure rate of 96%, was introduced in 2013. However, trials frequently excluded patients with advanced liver disease a...
Na minha lista:
| Udgivet i: | Perm J |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Permanente Journal
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378486/ https://ncbi.nlm.nih.gov/pubmed/28368787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/16-096 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|